OTC Markets OTCPK - Delayed Quote USD

Sorrento Therapeutics, Inc. (SRNE)

0.0100

-0.0005

(-4.76%)

As of 3:20 PM EDT. Market Open.

Currency in USD All numbers in thousands

Download

Breakdown

TTM

12/31/2022

12/31/2021

12/31/2020

12/31/2019

Total Revenue

64,270.0000

62,839.0000

52,904.0000

39,986.0000

31,432.0000

Cost of Revenue

35,629.0000

33,452.0000

13,031.0000

9,940.0000

12,237.0000

Gross Profit

28,641.0000

29,387.0000

39,873.0000

30,046.0000

19,195.0000

Operating Expense

384,162.0000

407,888.0000

407,918.0000

231,572.0000

214,377.0000

Operating Income

-355,521.0000

-378,501.0000

-368,045.0000

-201,526.0000

-195,182.0000

Net Non Operating Interest Income Expense

-6,811.0000

-8,574.0000

-10,224.0000

-20,157.0000

-35,048.0000

Other Income Expense

-190,426.0000

-174,672.0000

-84,259.0000

-88,897.0000

-129,346.0000

Pretax Income

-552,758.0000

-561,747.0000

-462,528.0000

-310,580.0000

-359,576.0000

Tax Provision

9,310.0000

-2,416.0000

-33,516.0000

-2,014.0000

-473.0000

Earnings from Equity Interest Net of Tax

-18,735.0000

-18,426.0000

-126.0000

-5,844.0000

-3,909.0000

Net Income Common Stockholders

-547,998.0000

-572,843.0000

-428,325.0000

-298,461.0000

-292,068.0000

Average Dilution Earnings

-38,669.0000

Diluted NI Available to Com Stockholders

-547,998.0000

-572,843.0000

-428,325.0000

-298,461.0000

-330,737.0000

Basic EPS

-1.10

-1.37

-1.45

-1.30

-2.20

Diluted EPS

-1.10

-1.37

-1.45

-1.30

-2.35

Basic Average Shares

507,859.0000

419,315.0000

294,774.0000

229,823.0000

132,732.0000

Diluted Average Shares

507,859.0000

419,315.0000

294,774.0000

229,823.0000

140,514.0000

Total Operating Income as Reported

-462,646.0000

-504,315.0000

-401,451.0000

-244,518.0000

-259,393.0000

Total Expenses

419,791.0000

441,340.0000

420,949.0000

241,512.0000

226,614.0000

Net Income from Continuing & Discontinued Operation

-547,998.0000

-572,843.0000

-428,325.0000

-298,461.0000

-292,068.0000

Normalized Income

-399,836.6600

-398,189.4067

-376,926.4447

-210,702.7949

-163,094.8796

Interest Income

24.0000

1,091.0000

Interest Expense

6,811.0000

8,574.0000

10,224.0000

20,157.0000

35,048.0000

Net Interest Income

-6,811.0000

-8,574.0000

-10,224.0000

-20,157.0000

-35,048.0000

EBIT

-545,947.0000

-553,173.0000

-452,304.0000

-290,423.0000

-324,528.0000

EBITDA

-532,020.0000

-539,928.0000

-439,842.0000

-279,416.0000

-313,539.0000

Reconciled Cost of Revenue

26,212.0000

24,532.0000

4,709.0000

2,986.0000

5,189.0000

Reconciled Depreciation

13,927.0000

13,245.0000

12,462.0000

11,007.0000

10,989.0000

Net Income from Continuing Operation Net Minority Interest

-547,998.0000

-572,843.0000

-428,325.0000

-298,461.0000

-292,068.0000

Total Unusual Items Excluding Goodwill

-187,546.0000

-175,408.0000

-55,414.0000

-88,331.0000

-129,143.0000

Total Unusual Items

-187,546.0000

-175,408.0000

-55,414.0000

-88,331.0000

-129,143.0000

Normalized EBITDA

-344,474.0000

-364,520.0000

-384,428.0000

-191,085.0000

-184,396.0000

Tax Rate for Calcs

0.0002

0.0000

0.0001

0.0000

Tax Effect of Unusual Items

-39,384.6600

-754.4067

-4,015.4447

-572.7949

-169.8796

12/31/2019 - 9/13/1999

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

VXRT Vaxart, Inc.

0.8253

-4.69%

INO Inovio Pharmaceuticals, Inc.

10.30

-6.36%

CELU Celularity Inc.

3.3300

-3.76%

CVAC CureVac N.V.

3.6250

-1.76%

NVAX Novavax, Inc.

15.43

-0.48%

OCGN Ocugen, Inc.

1.6790

-4.06%

SCPX Scorpius Holdings, Inc.

0.1120

+6.54%

JAGX Jaguar Health, Inc.

4.0899

-11.67%

GTBP GT Biopharma, Inc.

3.5200

-4.34%

IBRX ImmunityBio, Inc.

6.71

+2.84%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Sorrento Therapeutics, Inc. (SRNE)

Upgrade to begin using 40 years of financial statements and get so much more.

Related Tickers